The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease.
about
Adenosine monophosphate-activated protein kinase in diabetic nephropathyDiabetic Kidney Disease: A Syndrome Rather Than a Single Disease.Distinct urinary lipid profile in children with focal segmental glomerulosclerosisEffect of breviscapine injection on clinical parameters in diabetic nephropathy: A meta-analysis of randomized controlled trials.New molecular insights in diabetic nephropathy.Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis.Precision Medicine Approaches to Diabetic Kidney Disease: Tissue as an Issue.Vascular complications in diabetes: old messages, new thoughts.High Glucose Promotes CD36 Expression by Upregulating Peroxisome Proliferator-Activated Receptor γ Levels to Exacerbate Lipid Deposition in Renal Tubular Cells.Increasing the level of peroxisome proliferator-activated receptor γ coactivator-1α in podocytes results in collapsing glomerulopathy.CD36 in chronic kidney disease: novel insights and therapeutic opportunities.Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients.FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.Advances in the Understanding and Treatment of Mitochondrial Fatty Acid Oxidation Disorders.Shared and distinct lipid-lipid interactions in plasma and affected tissues in a diabetic mouse model.Mitochondrial energetics in the kidney.Highlighting Diabetes Mellitus: The Epidemic Continues.Crosstalk of Hyperglycemia and Dyslipidemia in Diabetic Kidney Disease.Location-Specific Oral Microbiome Possesses Features Associated With CKD.Orally active, species-independent novel A3 adenosine receptor antagonist protects against kidney injury in db/db mice.A Strategy for Discovery of Endocrine Interactions with Application to Whole-Body Metabolism.Benefit of Apabetalone on Plasma Proteins in Renal Disease.An Exome-wide Association Study for Type 2 Diabetes–Attributed End-Stage Kidney Disease in African Americans.
P2860
Q26745623-7EB08C1E-481C-4898-A3DB-D8EB37D15251Q33583012-BB29C69C-2B2D-4B75-8F91-ACD813D8E861Q37130343-8204504E-23DC-4F03-BAD0-CA6E88A99663Q37204321-504E56B3-BDF7-47B0-8F74-4B6F5704A471Q38694219-C74D985A-AF31-4D55-8A28-F116C3F96853Q39096507-82DE736F-F89A-4E11-9880-0F67BFD30097Q39212398-4464186F-5CC0-457D-A3D0-D7BE6637EF94Q39446720-41291EAB-E52E-4EDE-8C0B-19F466DC2F9DQ40215950-1194B96E-7EB3-4FEA-96D7-29D358F8DDB7Q41068117-30F94267-DA58-4033-9DFD-542AA30267E5Q41935783-FFC67A6A-BBF3-49A4-8DD2-D45D7F8C3C88Q46673943-29D207EC-E26A-4EED-A44F-510FD90DCE96Q46980569-8FA12763-331D-45A4-9FC0-62CEDA2AACD1Q47363157-95062E1F-AE8F-43AC-B3AD-475FA0A651CCQ47783538-DC2CEB3A-7BC3-46A0-939C-23EB098D5081Q47958098-8452DED2-DBBE-4841-BBA2-16C881EE427EQ49547709-87E8580F-3CC8-4E1D-9357-FC24BED60F0EQ49982517-E6CAE136-60EA-48EC-9C67-B5C763627AD6Q50016244-2DF6A5F1-46BC-4942-9829-68B1867182D0Q52576460-44868AF4-97E2-4190-B4DD-94B21D71394FQ53069547-74CA0E41-F736-442D-8CF7-88BA9BD61F4BQ55316265-6706411B-96DF-4D74-BD70-0AFC26708B91Q55483361-19914E16-B411-4CEA-9684-268C6A62E308
P2860
The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The evolving understanding of ...... sm to diabetic kidney disease.
@en
type
label
The evolving understanding of ...... sm to diabetic kidney disease.
@en
prefLabel
The evolving understanding of ...... sm to diabetic kidney disease.
@en
P2860
P1476
The evolving understanding of ...... sm to diabetic kidney disease.
@en
P2093
Ira J Goldberg
Krisztian Stadler
P2860
P2888
P356
10.1007/S11892-015-0611-8
P577
2015-07-01T00:00:00Z
P6179
1048068342